Metraipolis › archive › dc_1ecb4079d90d

Real-world use of disease-modifying therapy in persons with multiple sclerosis aged 55 and over — Europe PMC PMID:41000459

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41000459
DOI
10.1136/bmjno-2025-001108
License (as archived)
solo-consultazione
Archived
2026-11-09T19:51:57.659Z
SHA-256 of the archived text
84528b836e010eeebffa7ac9db43677d862197d1e611254423ca7fe7e75ddb8f
Stable URL of this page
https://metraipolis.com/documento/dc_1ecb4079d90d

How to cite

Real-world use of disease-modifying therapy in persons with multiple sclerosis aged 55 and over — Europe PMC PMID:41000459 — Europe PMC (en), https://europepmc.org/article/MED/41000459 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1ecb4079d90d (Metraipolis archive dc_1ecb4079d90d, sha256 84528b836e010eeebffa7ac9db43677d862197d1e611254423ca7fe7e75ddb8f)
BibTeX
@misc{dc1ecb4079d90d,
  title = {Real-world use of disease-modifying therapy in persons with multiple sclerosis aged 55 and over — Europe PMC PMID:41000459},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41000459},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1ecb4079d90d; sha256 84528b836e010eeebffa7ac9db43677d862197d1e611254423ca7fe7e75ddb8f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41000459. Agents can read the archived copy with the MCP tool read_document.